The largest database of trusted experimental protocols

Pierce gaussia luciferase glow assay kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Pierce Gaussia Luciferase Glow Assay Kit is a tool used to measure the activity of the Gaussia luciferase enzyme. Gaussia luciferase is a naturally secreted bioluminescent protein that can be used as a reporter for gene expression or protein secretion. The kit provides reagents for performing a sensitive and quantitative assay of Gaussia luciferase activity in cell culture supernatants or other samples.

Automatically generated - may contain errors

32 protocols using pierce gaussia luciferase glow assay kit

1

Quantifying HEV Replicon Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven days after transfection with rabbit HEV-3ra LRGluc indicator replicon, the cell culture medium (100 μL) was removed from a 96-well plate for analysis of extracellular luciferase expression activity. Cell culture media were collected at different time points to monitor the kinetic changes in luciferase expression activities. Luciferase activity was measured with the Pierce Gaussia Luciferase Glow assay kit (Thermo Scientific, Waltham, MA, USA). Briefly, 20 μL/well cell culture medium or cell lysate was added to each well of a black, opaque 96-well plate, followed by the addition of 50 μL Gaussia substrate. After 10 min incubation for signal stabilization, the luminescence was detected and recorded using a GloMax Discover microplate reader (Promega, Madison, WI, USA). Each LRG mutant replicon experiment was performed in quadruplicate. Luminescence-based antiviral assay for HEV was performed with ribavirin (Sigma-Aldrich, St. Louis, MO, USA) at a concentration of 1 μM or 10 μM following an established protocol (59 (link)).
+ Open protocol
+ Expand
2

siRNA Screening for MHV Replication Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
A custom siRNA library targeting each individual RTC-proximal factor (On Target Plus, SMART pool, 96-well plate format, Dharmacon, GE Healthcare) was ordered. Additionally, a deconvolved library of 4 individual siRNAs was purchased for selected targets. 10 nM siRNA were reverse transfected into L929 cells (8*103 cells per well) using Viromer Green (Lipocalyx) according to the manufacturer’s protocol. Cells were incubated 48 hr at 37°C 5% CO2 and cell viability was assessed using the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega). Cells were infected with MHV-Gluc (MOI = 0.05, 1000 plaque forming units/well), washed with PBS 3 h.p.i. and incubated in MEM+/+for additional 9 or 12 hr. Gaussia luciferase was measured from the supernatant using Pierce Gaussia Luciferase Glow Assay Kit (ThermoFisher Scientific). Experiments were carried out in four independent replicates and both cytotoxicity values and luciferase counts were normalized to the corresponding non-targeting scrambled control of each plate. A one-way ANOVA (Kruskal-Wallis test, uncorrected Dunn’s test) was used to test the statistical significance of reduced viral replication (mean <95% as compared to scramble control, n = 216). The R package ggplot2 was used to create the bubble plot (Figure 4b).
+ Open protocol
+ Expand
3

Gaussia Luciferase Assay in GSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gaussia luciferase plasmid (Addgene #22522) was transfected in GSCs using the Neon system (Life Technologies). 8000 transfected cells were plated in a 96-well plate 24h later and treated as indicated. Supernatants were then collected and analyzed for Gaussia luciferase activity using the Pierce Gaussia Luciferase Glow assay kit following manufacturers’ protocol (Thermo Scientific, 16160).
+ Open protocol
+ Expand
4

Gaussia Luciferase Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the standard Gaussia luciferase assay we tested 5 μl or 10 μl test samples and standards with the Pierce Gaussia Luciferase Glow Assay Kit (Thermo Scientific, Rockford, USA) or the Gaussia Glow-Juice Kit (PJK GmbH, Kleinbittersfeld, Germany) according to the manufacturer’s instructions, but adjusted to a 384-well format (50 μl or 55 μl total volume). Results are presented in relative light units (RLU).
+ Open protocol
+ Expand
5

Dual Secreted Luciferase Assay for ATF2 and c-JUN

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess ATF2 and c-JUN transcriptional activity, we implemented a dual secreted luciferase assay as previously described (20 (link)). At 48 hours after transfection, the cells were treated with specified drugs, and at the indicated times, media samples containing secreted lucifase were harvested and measured for luciferase activity using the Pierce Gaussia Luciferase Glow Assay Kit per manufacturer’s instructions (ThermoFisher).
+ Open protocol
+ Expand
6

Wnt Regulation of IDO1 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
COS7 cells were transfected with the pGL2-mIDO1 firefly luciferase reporter plasmid (a gift from A. Muller, Lankenau Institute for Medical Research, Philadelphia, PA), treated with Wnt3a, Wnt5a, and IFNγ. IDO promoter activation was analyzed using the Dual-Glo Luciferase Assay System. Wnt activity in conditioned medium (CM) was assayed with a HEK293-LEF1/TCF-luciferase reporter stable cell line and the Pierce Gaussia Luciferase Glow Assay Kit (ThermoScientific).
+ Open protocol
+ Expand
7

Gaussian Luciferase Assay for Rabies Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recombinant rabies virus strain 1088 expressing gaussia luciferase (1088/GLuc) was generated as described previously4. The virus titer was determined using focus assay as reported5 and expressed as focus forming units (FFU). N2a cells (4 × 104 cells per well) and 1088/GLuc (4 × 102 FFU per well) were prepared in E-MEM containing 10% fetal bovine serum and antibiotics, and the mixed solution was applied to a 96-well black plate with clear bottoms (Greiner). Subsequently, various concentrations of compounds were prepared in the medium and added to each well. The microplates were incubated at 37 ℃ under 5% CO2 for 3 days, and then, a luciferase reporter gene assay was performed using Pierce Gaussia Luciferase Glow Assay Kit (Thermo Fisher Scientific). The substrate solution was added to each well, and RLU was immediately measured using a microplate luminometer LuMate (Awareness Technology). Based on the RLU value, IC50 was determined from semilogarithmic dose–response plots.
+ Open protocol
+ Expand
8

Gaussia Luciferase Bioluminescence Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
GLuc bioluminescence was measured 72 h post transfection, employing the Pierce Gaussia Luciferase Glow Assay Kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. Briefly, 20 μL of supernatant from each well was transferred into a flat, white, opaque, 96-well plate (Thermo Scientific, Waltham, MA, USA) and mixed with 50 μL of fresh working solution (i.e., 49.5 μL Gaussia Glow Assay buffer and 0.5 μL 100× Coelenterazine) at room temperature. Bioluminescence (RLU) was measured immediately (integration time 2000 milliseconds) in an Infinite F200 Pro luminometer (Tecan, Männedorf, Switzerland).
+ Open protocol
+ Expand
9

HIF1α Transcriptional Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A HIF1α-responsive element (HRE)-Gaussia Luciferase reporter system (Cavadas et al., 2018 (link)) was used to assess HIF1α functional activity in Caco-2-HIF1A-null cells and empty vector controls. Caco-2 cells were transfected with 1 mg of the HRE-Gaussia Luciferase reporter construct in antibiotic-free media using Lipofectamine 2000 for 24 h, after which cells were treated with 1 mM DMOG for up to 48 h. Secreted luciferase was indicative of HRE-activity. Bioluminescence was quantified in media samples using the PierceGaussia Luciferase Glow Assay Kit (Thermo Scientific, 16161), carried out in a 96-well plate as per manufacturer’s instructions. Luminescence was determined using the CLARIOstar microplate reader (BMG Labtech, Ortenberg, Germany). Relative Luminescence Units (RLU) are presented normalized to total protein content (μg) for comparison of HIF1α functional activity levels.
+ Open protocol
+ Expand
10

Modulation of HBV Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Constructs containing either HBsAg or the Gaussia luciferase (Gluc) reporter genes were synthesized (GenScript). The H133 encodes the full HBsAg transcript sequence (spanning nt 2 to 1991; GenBank accession no. U95551) under the regulation of tetracycline-controlled cytomegalovirus (CMV) promoter. The H133_dSLα and H133_dLa are derived from H133 with either the SLα sequence (nt 1294 to 1322) or the La protein binding site (nt 1271 to 1294) deleted, respectively. In the luciferase-based constructs, the HBsAg encoding region was replaced with Gluc (the Gluc constructs). Variants were introduced into the Gluc constructs in which the HBx coding sequence was deleted with either wild-type SLα (Gluc_dHBx) or an inverted SLα sequence (Gluc_rcSLα). Huh-7 cells were transfected with the HBsAg or luciferase reporter-derived plasmids per the manufacturer’s instructions (Lipofectamine 3000; Invitrogen, MA, USA). Cells were treated with the indicated compounds for 5 days. Culture supernatants were used for HBsAg or luciferase measurement (Pierce Gaussia Luciferase Glow assay kit; Thermo Fisher Scientific, Waltham, MA, USA). Cells were collected for HBV RNA transcript and cellular rRNA analysis by Northern blotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!